[Federal Register Volume 87, Number 228 (Tuesday, November 29, 2022)]
[Notices]
[Pages 73308-73309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26001]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Award of a Single-Source Cooperative Agreement To Fund 
the World Health Organization (WHO)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), located 
within the Department of Health and Human Services (HHS), announces the 
award of approximately $80,000,000, for Year 1 funding to WHO. The 
award will support WHO's efforts to support national governments with 
polio eradication, measles and rubella mortality reduction, and other 
vaccine preventable disease (VPD) control efforts. Funding amounts for 
years 2-5 will be set at continuation.

DATES: The period for this award will be July 1, 2023, through June 30, 
2028.

FOR FURTHER INFORMATION CONTACT: Karen Clackum, Center for Global 
Health, Global Immunization Division, Centers for Disease Control and 
Prevention, 1600 Clifton Rd. NE, Bldg. 21, Atlanta, GA, 30329, 
Telephone: 770-488-2680, E-Mail: [email protected].

SUPPLEMENTARY INFORMATION: The single-source award will support WHO in 
strengthening immunization systems; maintaining and strengthening field 
and laboratory-based surveillance; ensuring capacities to quickly and 
effectively detect and respond to VPD outbreaks; foster immunization 
program sustainability; improve immunization program, policies, 
guidelines, and practices at country, regional, and global levels; and 
ensure sustained political, technical, and financial support for the 
Global Polio Eradication Initiative (GPEI), Measles and Rubella 
Partnership, and other disease-specific initiatives as well as for the 
Immunization Agenda 2030.
    WHO is in a unique position to conduct this work, as it is the only

[[Page 73309]]

organization with a worldwide mandate for the control and prevention of 
vaccine preventable diseases (VPDs). WHO also has the lead 
responsibility among United Nations (UN) organizations for implementing 
the World Health Assembly (WHA) resolutions calling for the global 
eradication of polio, elimination of rubella, and multiple other 
resolutions with targeted VPD goals. Additionally, no other global 
partner or agency has the technical expertise and direct access to 
implementation of immunization activities in such a breadth of 
countries.

Summary of the Award

    Recipient: World Health Organization (WHO).
    Purpose of the Award: The purpose of this award is to support WHO's 
efforts to support national governments with polio eradication, measles 
and rubella mortality reduction, and other vaccine preventable disease 
(VPD) control efforts in line with CDC's Global Immunization Strategic 
Framework (GISF).
    Amount of Award: The approximate year 1 funding amount will be 
$80,000,000 in Federal Fiscal Year (FYY) 2023 funds, subject to the 
availability of funds. Funding amounts for years 2-5 will be set at 
continuation.
    Authority: This program is authorized under Sections 301 (c), 307, 
and 317 of the Public Health Service Act (42 U.S.C. 241 (c), 242l, and 
247b); and section 104 of the Foreign Assistance Act of 1961 (22 U.S.C. 
2151b).

    Period of Performance: July 1, 2023 through June 30, 2028.

    Dated: November 23, 2022.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-26001 Filed 11-28-22; 8:45 am]
BILLING CODE 4163-18-P